How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll.
Related Posts
Trump’s Colombia Tariff Threat Startled Companies Trying to Rely Less on China
By declaring he’d put tariffs on goods from the South American country, the president imperiled a growing influx of foreign investment there.
Insurers Pledge to Ease Controversial Prior Approvals for Medical Care
Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.
Markets Rise, Taking Steeper Tariffs in Stride
Major indexes in Asia and Europe posted gains and U.S. futures climbed in premarket trading.